Diet and exercise may boost GLP-1 drug success in diabetic women

NCT ID NCT07027995

Recruiting now Disease control Sponsor: Ohio State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a 24-week program of healthy eating and exercise helps post-menopausal women with type 2 diabetes and heart-kidney problems stick to their new GLP-1 medication. Researchers will track how many women stop taking the drug and measure changes in heart disease risk. The goal is to see if lifestyle support can improve long-term disease control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior Body Weight cardiovascular-kidney-metabolic syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME TYPE 2 DIABETES

Contacts and locations

Locations

Martha Morehouse
RECRUITING

Columbus, Ohio, 43221, United States
Ohio State East Hospital
NOT_YET_RECRUITING

Columbus, Ohio, 43203, United States
Ohio State Healthy Community Center
ACTIVE_NOT_RECRUITING

Columbus, Ohio, 43062, United States
Ohio State Outpatient Care Upper Arlington
ACTIVE_NOT_RECRUITING

Upper Arlington, Ohio, 43221, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.